TEMODAR (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the TEMODAR drug offered from Merck Sharp & Dohme Corp.. This Alkylating Activity [MoA],Alkylating Drug [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Temozolomide |
| SUBSTANCE NAME: | TEMOZOLOMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Alkylating Activity [MoA],Alkylating Drug [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2009-02-27 |
| END MARKETING DATE: | 0000-00-00 |
TEMODAR HUMAN PRESCRIPTION DRUG Details:
| Item Description | TEMODAR from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2009-02-27 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0085-1381_41e18e8c-a81f-4ff1-a4a9-4434c709b059 |
| PRODUCT NDC: | 0085-1381 |
| APPLICATION NUMBER: | NDA022277 |
Other TEMOZOLOMIDE Pharmaceutical Manufacturers / Labelers:
